ei ole lubatud
ei ole lubatud
Digitaalõiguste kaitse (DRM)
Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).
Vajalik tarkvara
Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)
PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )
Seda e-raamatut ei saa lugeda Amazon Kindle's.
Chapter
1. The Pillars of Sustainable Pharmaceutical Development.
Chapter
2. Ecodesign Principles.
Chapter
3. Sustainable Pharmaceutical Product Development and Optimization Processes.
Chapter
4. Eco-friendly Pharmaceutical Formulation and Production Strategies and Future Perspectives.
Chapter
5. Design of Experiments (DoE) in Manufacturing Process Optimization.
Chapter
6. IoT and Its Role in Sustainable Pharmaceutical Supply Chains.
Chapter
7. Analysis of the Process and Evaluation of Green Servitization: Sustainability Practices of the Pharmaceutical Industry.
Chapter
8. Design Strategies for Waste Reduction and Enhanced Recyclability in Pharmaceutical Packaging.
Chapter
9. Pharmaceutical Waste Reduction in Hospitals: The Impact of Segregation Practices and Regulatory Compliance.
Chapter
10. Deep Eutectic Solvents for Sustainable Phytochemical Extraction in Pharmaceutical Innovation.
Chapter
11. Invasive Plant-derived Phytochemicals: Turning Threat into Benefit.
Chapter
12. Current Approaches to Food Waste Valorization for Nutraceuticals.
Chapter
13. Eco-friendly Nanoparticle Synthesis for Cancer Treatment: A Sustainable Healthcare Approach.
Chapter
14. Sustainable Strategies for Cancer Phytomedicine: Balancing Efficacy and Environmental Responsibility.
Chapter
15. Enhancing Medicine Quality Sustainably: Evaluating the Impact of WHO Guidelines through Document Analysis.
Chapter
16. Challenges in Sustainable Pharmaceutical Development.
Chapter
17. Sustainable Pharma Case Studies.